We've detected an Ad Blocker in your browser.

Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.

Menu

24–25 March




REGISTER FREE

LOG IN

Please enter your email address

Having trouble logging in? Please email info@radcliffe-group.com

validation result

Please choose one of the options shown

Please enter your registration lead id

Please enter your registration session id

Please enter your successful log-in count

feed resp param id

Please choose one of the options shown

A global virtual event dedicated to the latest cardiorenal metabolic disease treatment strategies to support better patient outcomes

Overview

KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to introduce e-SPACE Cardio-Renal-Metabolic 2023 to be held 24–25 March.

e-SPACE Cardio-Renal-Metabolic 2023 will deliver best-in-class free-to-access virtual education. Bringing together thought-leaders from across the globe, e-SPACE Cardio-Renal-Metabolic 2023 will both optimise geographical reach whilst delivering both global and regional insight.

A thoughtfully curated programme will support the exploration of how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Antonio Ceriello (IRCCS MultiMedica, Milan, IT), Prof Tara I. Chang (Stanford University, California, US), Prof Ian de Boer (University of Washington, Washington, US), Prof Peter Rossing (University of Copenhagen, Copenhagen, DK) and Prof Shelley Zieroth (University of Manitoba, Manitoba, CA ) will lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

Following on from the success of e-SPACE Heart Failure 2022, e-SPACE Cardio-Renal-Metabolic 2023 will again bring together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

Underpinned by this combined expertise in educational content and delivery, and led by an international faculty of global standing, e-SPACE Cardio-Renal-Metabolic 2023 promises to be the widest reaching and most engaging to date.

Register now to join us.

REGISTER FREE NOW

REGISTER NOW

Register Now

This live conference starts in:

DAYS
:

HOURS
:

MINS
:

SECS

Course Leadership

Prof Stefan Anker
Prof Stefan Anker

CHAIR
Charité Campus Virchow-Klinikum, Berlin, DE

Prof Stefan Anker studied medicine at Charité Medical School of Humboldt-University Berlin, Germany from 1987 to 1993. He went on to complete his PhD at the National Heart and Lung Institute of Imperial College London, United Kingdom, in 1998. Since then, he has had teaching appointments in several countries including the UK, Germany, Australia and Italy.
He has worked as a Junior Professor and then as Professor for Charité Campus Virchow-Klinikum since 2002. He is a member of and serves on the Boards of several academic organizations, including the Board of the Heart Failure Association of the European Society of Cardiology and the Editorial Board of the Journal of Cachexia, Sarcopenia and Muscle (SCWD). He is also a member of the German Centre for Cardiovascular Research (DZHK).

More info

Less info

Dr Javed Butler
Dr Javed Butler

CO-CHAIR
Baylor Scott and White Research Institute, Texas, US

Dr Javed Butler is Professor and Chair of the Department of Medicine at University of Mississippi Medical Center in Jackson Mississippi, and also Patrick H Lehan Chair of Cardiovascular Research. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He has authored more than 900 peer-reviewed publications. Previously, he was Director of the Division of Cardiovascular Medicine and Co-director of the Heart Institute at State University of New York (SUNY) Stony Brook University.

More info

Less info

 Prof Antonio Ceriello
Prof Antonio Ceriello

CHAIR
IRCCS MultiMedica, Milan, IT

Prof Antonio Ceriello is Head of Diabetes Department at IRCCS MultiMedica, Milan, IT. Prof Ceriello has chaired the International Diabetes Federation (IDF) committee for the development in 2008, and in the 2011 for the update of “Guideline for Management of Postmeal Glucose ”. Currently, he is the President of the European Association for the Study of Diabetes (EASD) Study Group on “Diabetes and CardiovascularDiseases”.

More info

Less info

Prof Tara I. Chang
Prof Tara I. Chang

CO-CHAIR
Stanford University, California, US

Prof Tara I. Chang, is an Associate Professor of Medicine and Chief of the Division of Nephrology at Stanford University, California, US. Her research program focuses on hypertension and cardiovascular outcomes in CKD. Prof Chang is a certified Hypertension Specialist and is part of the Stanford Hypertension Center which provides innovative care for patients with severe hypertension.

More info

Less info

Prof Ian de Boer
Prof Ian de Boer

CHAIR
University of Washington, Washington, US

Prof Ian de Boer is a Nephrologist, Professor of Medicine, and Adjunct Professor of Epidemiology at the University of Washington, Washington, US. His research focuses on the metabolic causes and consequences of chronic kidney disease. Prof de Boer focuses on the development, progression, and complications of diabetic kidney disease, and the role of impaired mineral metabolism in the pathogenesis of chronic kidney disease and cardiovascular diseases.

More info

Less info

Prof Peter Rossing
Prof Peter Rossing

CHAIR
University of Copenhagen, Copenhagen, DK

Prof Peter Rossing is a clinician researcher devoted to complications in diabetes with focus on renal and cardiovascular complications. He obtained a specialist degree in internal medicine and endocrinology 2004. Since 2007 he has been a chief physician and manager of the Steno Diabetes Center research team dedicated to the research of micro-and macrovascular complications of diabetes. And since 2012, Professor in diabetic angiopathy at University of Copenhagen, Copenhagen, DK. He is coordinator of the EU FP7 project PRIORITY aiming to test if urinary proteomics can be used to stratify prevention of renal complications in type 2 diabetes, and the Novo Nordisk Foundation grant PROTON aiming at personalising prevention of diabetic nephropathy.

More info

Less info

Prof Shelley Zieroth
Prof Shelley Zieroth

CO-CHAIR
University of Manitoba, Manitoba, CA

Dr Shelley Zieroth is at SBH Heart Failure and Transplant Clinics and serves as Head of the Medical Heart Failure Program, WRHA Cardiac Sciences Program, and as Associate Professor of the Section of Cardiology at the University of Manitoba, CA. Dr Zieroth attended medical school at the University of Manitoba, where she went on to train in internal medicine and cardiology. She completed her postdoctoral clinical fellowship, specializing in advanced heart failure and cardiac transplant, at Toronto General Hospital. She has lectured internationally on the subject of heart failure. Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.

More info

Less info

Register now

Programme

(Please note this programme is subject to change)

Friday, 24 March 2023 (Day 1)
Bangkok Time (ICT)
Paris Time (CET)
Rio Time (BRT)
Part 1
14:20-14:50
08:20-08:50
04:20-04:50
Meet the expert / Case discussion
Break
15:00-16:00
09:00-10:00
05:00-06:00
Plenary session 1: HFpEF
Break
16:10-16:50
10:10-10:50
06:10-06:50
Industry sponsored session
Break
17:00-18:00
11:00-12:00
07:00-08:00
Plenary session 2: SGLT2 updates
Break
18:10-18:40
12:10-12:40
08:10-08:40
Meet the expert / Case discussion
Part 2
20:20-20:50
14:20-14:50
10:20-10:50
Meet the expert / Case discussion
Break
21:00-22:00
15:00-16:00
11:00-12:00
Plenary session 3: Weight management in CRM disease
Break
22:10-22:50
16:10-16:50
12:10-12:50
Industry sponsored session
Break
23:00-00:00
17:00-18:00
13:00-14:00
Plenary session 4: Guidelines implementation for acutely ill patients
Part 3
00:20-00:50
18:20-18:50
14:20-14:50
Meet the expert / Case discussion
Break
01:00-02:00
19:00-20:00
15:00-16:00
Plenary session 5: Mineralocorticoids antagonists in CRM disease
Break
02:10-02:50
20:10-20:50
16:10-16:50
Industry sponsored session
Break
03:00-04:00
21:00-22:00
17:00-18:00
Plenary session 6: Diuretics: old drugs, new data, new approaches
Break
04:10-04:40
22:10-22:40
18:10-18:40
Meet the expert / Case discussion
Saturday, 25 March 2023 (Day 2)
Bangkok Time (ICT)
Paris Time (CET)
Rio Time (BRT)
Part 4
14:20-14:50
08:20-08:50
04:20-04:50
Meet the expert / Case discussion
Break
15:00-16:00
09:00-10:00
05:00-06:00
Plenary session 7: CRM drug management in patients with low eGFR and type 2 diabetes
Break
16:10-16:50
10:10-10:50
06:10-06:50
Industry sponsored session
Break
17:00-18:00
11:00-12:00
07:00-08:00
Plenary session 8: Diabetes and cardio-renal disease: the relevance of early treatment with the right drug
Part 5
20:20-20:50
14:20-14:50
10:20-10:50
Meet the expert / Case discussion
Break
21:00-22:00
15:00-16:00
11:00-12:00
Plenary session 9: Managing “metals”
Break
22:10-22:50
16:10-16:50
12:10-12:50
Industry sponsored session
Break
23:00-00:00
17:00-18:00
13:00-14:00
Plenary session 10: Management of diabetes with kidney disease
Part 6
00:20-00:50
18:20-18:50
14:20-14:50
Meet the expert / Case discussion
Break
01:00-02:00
19:00-20:00
15:00-16:00
Plenary session 11: Managing frail and elderly patients
Break
02:10-02:50
20:10-20:50
16:10-16:50
Industry sponsored session
Break
03:00-04:00
21:00-22:00
17:00-18:00
Plenary session 12: Managing end-stage disease: focus on QoL

Target Audience

  • Cardiologists
  • Nephrologists
  • Diabetologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

Learning Objectives

  • Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
  • Describe the complexity and interlink between the three conditions
  • Discuss existing guidelines and best approaches for screening patients
  • Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
  • Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes


If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com

About KDIGO

KDIGO is a global organisation developing and implementing evidence-based clinical practice guidelines in kidney disease. It is an independent, volunteer-led, self-managed foundation incorporated in Belgium and accountable to the public and the patients it serves.

KDIGO’s mission is to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines.

For more information on KDIGO, please visit https://kdigo.org.

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community.

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking

Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.

Please contact events@radcliffe-group.com should you have any queries.